EUVIMEDEUVIMED entdecken
Crossref

Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan

Shumaila Arif, Noor Muhammad, Humaira Naeemi, Muhammad Usman Rashid iD

Familial Cancer · 2025

DOI: 10.1007/s10689-025-00515-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, 2025. Verfasst von Shumaila Arif und 3 weiteren Autor:innen. Beteiligte Einrichtung: Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), 7 A, Block R3, Johar Town, Lahore, Punjab, 54000, Pa…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Germ-Line Mutation, Cyclin-Dependent Kinase Inhibitor p16, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is a highly aggressive malignancy, with 10%-20% of cases linked to inherited genetic risk factors. Pathogenic variants (PVs) in the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene have been associated with pancreatic cancer among Caucasians. However, data from South Asians are lacking. We investigated the prevalence of CDKN2A germline variants in 200 consecutively and prospectively enrolled, unselected pancreatic cancer patients from Pakistan. Comprehensive variant detection was performed using high-resolution melting analyses followed by DNA sequencing. Novel variants were investigated for pathogenicity using in-silico tools, and potentially functional variants were screened in 200 healthy controls. Five unique CDKN2A variants were identified, including one novel synonymous variant c.285G > T (p.Val95Val), one missense variant c.442G > A (p.Ala148Thr), one intronic variant (c.150 + 32A > T), and two variants (c.*29G > C and c.*69C > T) in the 3' untranslated region. No PVs in CDKN2A were detected. All variants were classified as benign, except the novel synonymous variant (p.Val95Val), which was categorized as a variant of uncertain significance (VUS) based on in-silico protein function prediction scores (Revel 0.38; PhyloP 2.88). This variant was identified in a 61-year-old male patient of Punjabi ethnicity with Grade 2 periampullary ductal adenocarcinoma with lymphovascular invasion and was absent in 200 healthy controls. Our study showed that CDKN2A PVs are very rare among unselected Pakistani pancreatic cancer patients, suggesting a negligible contribution to inherited pancreatic cancer risk in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsGerm-Line MutationCyclin-Dependent Kinase Inhibitor p16Carcinoma, Pancreatic DuctalHumansPakistanMaleMiddle AgedFemaleAgedCase-Control StudiesGenetic Predisposition to DiseaseProspective StudiesAdult

Stichwörter der Autor:innen

CDKN2AGermline variantsPakistanPancreatic cancer

Substanzen

CDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), 7 A, Block R3, Johar Town, Lahore, Punjab, 54000, Pakistan.
  • Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), 7 A, Block R3, Johar Town, Lahore, Punjab, 54000, Pakistan. usmanr@skm.org.pk.

ORCID-Profile: Muhammad Usman Rashid

Zitieren

APA

Arif, S., Muhammad, N., Naeemi, H., & Rashid, M. U. (2025). Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan. Familial Cancer. https://doi.org/10.1007/s10689-025-00515-2

Vancouver

Arif S, Muhammad N, Naeemi H, Rashid MU. Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan. Familial Cancer. 2025. doi:10.1007/s10689-025-00515-2

BibTeX
@article{Arif2025,
  author = {Arif, Shumaila and Muhammad, Noor and Naeemi, Humaira and Rashid, Muhammad Usman},
  title = {Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan},
  journal = {Familial Cancer},
  year = {2025},
  doi = {10.1007/s10689-025-00515-2}
}
Kostenlos starten →